Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Research & Development: 2012-2016

Historic Research & Development for Tvardi Therapeutics (TVRD) over the last 5 years, with Dec 2016 value amounting to $49.3 million.

  • Tvardi Therapeutics' Research & Development fell 5.38% to $9.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was $57.2 million, marking a year-over-year increase of 56.59%. This contributed to the annual value of $49.3 million for FY2016, which is 132.10% up from last year.
  • As of FY2016, Tvardi Therapeutics' Research & Development stood at $49.3 million, which was up 132.10% from $21.2 million recorded in FY2015.
  • Over the past 5 years, Tvardi Therapeutics' Research & Development peaked at $49.3 million during FY2016, and registered a low of $4.6 million during FY2012.
  • In the last 3 years, Tvardi Therapeutics' Research & Development had a median value of $21.2 million in 2015 and averaged $28.5 million.
  • Data for Tvardi Therapeutics' Research & Development shows a peak YoY skyrocketed of 132.10% (in 2016) over the last 5 years.
  • Over the past 5 years, Tvardi Therapeutics' Research & Development (Yearly) stood at $4.6 million in 2012, then skyrocketed by 88.93% to $8.7 million in 2013, then soared by 73.49% to $15.1 million in 2014, then soared by 40.83% to $21.2 million in 2015, then skyrocketed by 132.10% to $49.3 million in 2016.